The Securities and Exchange Board of India (Sebi) has issued observations for eight initial public offerings, a move that market participants say could rekindle interest in listings. The approvals cover a diverse set of companies, from fertility chain Indira IVF to manufacturing and services firms, and come as equity markets keep a watch on fresh supply and investor appetite.
India IPO approvals highlight market activity
Sebi’s observations were issued for Indira IVF and Rays of Belief, both of which had adopted confidential filings, as well as for Chartered Speed, Glass Wall Systems India, Shriram Food Industry, RKCPL, Tempsens Instruments and Jerai Fitness. Observations from Sebi usually signal that the regulator has cleared the technical aspects of an offer document. For companies that used confidential filings, however, the next step is to make the draft offer public so investors can provide feedback before the issue proceeds to formal clearance.
Indira IVF, a prominent fertility chain, refiled its draft red herring prospectus in July 2025 after withdrawing an earlier draft offer document in March last year. Confidential filing allows a company to submit its offer document to the regulator without releasing it to the market immediately. Once Sebi raises observations, the company must publish the document and invite public comments, giving retail and institutional investors an opportunity to review the details ahead of listing.
Analysts say the approvals cover a range of sectors, reflecting the broader diversification of capital-market activity in India. Market participants will watch pricing windows and anchor investor interest closely, particularly for names that have opted for confidential filings. The presence of several manufacturing and services companies among the eight approvals points to a steady pipeline of mid-cap and sector-specific listings.
The approvals arrive amid a year in which 103 firms raised capital via initial public offerings, according to the report, mobilising Rs 1.75 billion. While headline fundraising figures vary by source, the steady number of issues indicates continued appetite for new listings among Indian issuers and investors.
Market watchers also noted corporate leadership news on the same day. Portfolio management services firm Aequitas confirmed the sudden death of its managing director, Siddhartha Bhaiya, who collapsed from cardiac arrest while on vacation in New Zealand. Bhaiya, 47, founded Aequitas in 2012 and had been central to its growth. The firm paid tribute to his leadership and analytical rigour.
Industry sources said Bhaiya’s passing will be a personal loss to many in the asset-management community, though it is not expected to have a systematic impact on capital markets. Together with the Sebi observations, the two developments made for a busy set of headlines for market participants assessing near-term supply and leadership changes in financial services.
For the companies that have received Sebi observations, the timeline now depends on when confidential filers publish their draft prospectuses for public feedback and how quickly any queries are resolved. If pricing windows open and investor interest holds, these issues could add to the pipeline of listings and provide fresh opportunities for portfolio deployment.
Investors and advisers will be monitoring the public disclosures closely to gauge valuations and subscription guidance. Sebi observations are a necessary step, but market success will ultimately depend on pricing, investor demand, and the broader economic outlook.
Key Takeaways:
- SEBI has issued observations for eight IPOs, signalling renewed momentum in India IPO approvals.
- Indira IVF and Rays of Belief filed confidential draft documents, which will be made public after Sebi observations.
- Market context: 103 firms raised funds through IPOs in 2025, while corporate leadership news added to market headlines.
- Aequitas MD Siddhartha Bhaiya died of a sudden cardiac arrest, prompting industry condolences.
